September 2014, Vol 4 No 1

← Back to Issue

A Focus on Polycythemia Vera and Myelofibrosis: Updates from ASCO and EHA 2014

In spring and summer 2014, internationally renowned physicians, nurses, pharmacists, payers, basic scientists, and other members of the healthcare team involved in the care of patients with solid tumors and hematologic malignancies gathered at the Annual Meeting of the American Society of Clinical Oncology and the 19th Congress of the European Hematology Association.

Following these meetings, Ruben A. Mesa, MD, FACP, and Emily Knight, RN, BSN, OCN, from the Mayo Clinic Cancer Center, and Atheer A. Kaddis, PharmD, from Diplomat Specialty Pharmacy, provided insight and opinion about some of the key presentations on polycythemia vera (PV) and myelofibrosis (MF). This supplement is designed to provide community oncology practitioners with a clinically useful review and expert commentaries on key studies reported at ASCO and EHA 2014.

Read More